BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28548934)

  • 1. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.
    Lu J; Yang Y; Guo G; Liu Y; Zhang Z; Dong S; Nan Y; Zhao Z; Zhong Y; Huang Q
    Oncotarget; 2017 Jul; 8(30):49502-49514. PubMed ID: 28548934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing IKBKE inhibits the migration and invasion of glioblastoma by promoting Snail1 degradation.
    Liu Y; Guo G; Lu Y; Chen X; Zhu L; Zhao L; Li C; Zhang Z; Jin X; Dong J; Yang X; Huang Q
    Clin Transl Oncol; 2022 May; 24(5):816-828. PubMed ID: 34741724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway.
    Wang X; Lu J; Li J; Liu Y; Guo G; Huang Q
    J Transl Med; 2021 Sep; 19(1):396. PubMed ID: 34544426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation.
    Guo JP; Coppola D; Cheng JQ
    J Biol Chem; 2011 Oct; 286(43):37389-98. PubMed ID: 21908616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines.
    Liu Y; Lu J; Zhang Z; Zhu L; Dong S; Guo G; Li R; Nan Y; Yu K; Zhong Y; Huang Q
    Cell Death Dis; 2017 Aug; 8(8):e3022. PubMed ID: 29048430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway.
    Bainbridge A; Walker S; Smith J; Patterson K; Dutt A; Ng YM; Thomas HD; Wilson L; McCullough B; Jones D; Maan A; Banks P; McCracken SR; Gaughan L; Robson CN; Coffey K
    Nucleic Acids Res; 2020 Jun; 48(10):5366-5382. PubMed ID: 32324216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated TEAD-binding protein of TAZ inhibits glioma survival through the induction of apoptosis and repression of epithelial-mesenchymal transition.
    Zhao W; Li LW; Tian RF; Dong QF; Li PQ; Yan ZF; Yang X; Huo JL; Fei Z; Zhen HN
    J Cell Biochem; 2019 Oct; 120(10):17337-17344. PubMed ID: 31209945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-κB-Snail signaling in glioma.
    Zhang B; Shi L; Lu S; Sun X; Liu Y; Li H; Wang X; Zhao C; Zhang H; Wang Y
    Cancer Biol Ther; 2015; 16(6):898-911. PubMed ID: 25870011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
    Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
    Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma.
    Sun Y; Guo G; Zhang Y; Chen X; Lu Y; Hong R; Xiong J; Li J; Hu X; Wang S; Liu Y; Zhang Z; Yang X; Nan Y; Huang Q
    Cell Signal; 2024 Apr; 116():111062. PubMed ID: 38242271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gremlin1 promotes carcinogenesis of glioma in vitro.
    Guan Y; Cheng W; Zou C; Wang T; Cao Z
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):244-256. PubMed ID: 27862197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs let-7b/i suppress human glioma cell invasion and migration by targeting IKBKE directly.
    Tian Y; Hao S; Ye M; Zhang A; Nan Y; Wang G; Jia Z; Yu K; Guo L; Pu P; Huang Q; Zhong Y
    Biochem Biophys Res Commun; 2015 Mar; 458(2):307-12. PubMed ID: 25656572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway.
    Wang Y; Liu J; Ying X; Lin PC; Zhou BP
    Sci Rep; 2016 Apr; 6():24606. PubMed ID: 27094683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of CXCR4 silencing on epithelial-mesenchymal transition related genes in glioma U87 cells.
    Zhu Y; Yang P; Wang Q; Hu J; Xue J; Li G; Zhang G; Li X; Li W; Zhou C; Zhao M; Wang D
    Anat Rec (Hoboken); 2013 Dec; 296(12):1850-6. PubMed ID: 24150861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Diterpenoid Isoferritin A (IsoA) Inhibits Glioma Cell Growth and Metastasis via Regulating of TGFβ-Induced EMT Signal Pathway.
    Shen B; Sun D
    Med Sci Monit; 2018 Jun; 24():3815-3823. PubMed ID: 29873321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in IKBKE as a potential target for cancer therapy.
    Yin M; Wang X; Lu J
    Cancer Med; 2020 Jan; 9(1):247-258. PubMed ID: 31733040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma.
    Song Y; Zheng S; Wang J; Long H; Fang L; Wang G; Li Z; Que T; Liu Y; Li Y; Zhang X; Fang W; Qi S
    Oncotarget; 2017 Jun; 8(26):41947-41962. PubMed ID: 28410212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma.
    Song C; Fan B; Xiao Z
    Biomed Pharmacother; 2018 Feb; 98():440-445. PubMed ID: 29278854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.